Global Rank
#4798
Country Rank
#968
Market Cap
3.12 B
Price
4.14
Change (%)
0.30%
Volume
5.51 M
China National Medicines Corporation Ltd. (SHA-600511) Stock Split History
This company has undergone a total of three stock splits throughout its history. Two forward splits were executed, enhancing liquidity and increasing share accessibility. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 06/03/2009 with a ratio of 2-for-1. If an investor had purchased one share prior to the first split on 08/23/2006, that single share would now have grown to 3.6 shares. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Date | Split Ratio | Multiple | Cumulative multiple | Type |
---|---|---|---|---|
06/03/2009 | 2:1 | x2 | x3.6 | Forward |
06/25/2008 | 1.8:1 | x1.8 | x1.8 | Forward |
08/23/2006 | 1:1 | x1 | x1 | Reverse |
Frequently Asked Questions
-
How much would China National Medicines Corporation Ltd. stock be worth if it never split?If China National Medicines Corporation Ltd. (stock symbol: SHA-600511) had never undergone any stock splits, its price per share today would be approximately 14.90 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 2-for-1) that occurred on 06/03/2009.
-
Has China National Medicines Corporation Ltd. stock ever split?China National Medicines Corporation Ltd. (stock symbol: SHA-600511) has undergone a total of three stock splits. The most recent split occurred on 06/03/2009. One share bought prior to the first split on 08/23/2006 would now equal 3.60 shares.
-
Will China National Medicines Corporation Ltd. stock split again?China National Medicines Corporation Ltd. (stock symbol: SHA-600511) has undergone three stock splits in its history. The most recent split, a 1-for-1 split, occurred on 06/03/2009. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.